A retrospective, single center study analysing PBSC Mobilization for Auto-HSCT in Myeloma
Latest Information Update: 06 Jan 2021
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Doxorubicin (Primary) ; Filgrastim (Primary) ; Plerixafor (Primary) ; Vincristine (Primary) ; Granulocyte colony-stimulating factors
- Indications Multiple myeloma
- Focus Therapeutic Use
- 06 Jan 2021 New trial record
- 08 Dec 2020 Primary endpoint has not been met. (overall survival (OS))
- 08 Dec 2020 Primary endpoint has not been met. (progression-free survival (PFS))